Ledger.Open graph →
SEC Form D · filed September 17, 2021

Santi Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Waltham, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David Grayzel · Waltham, MADirectorJoshua Resnick · Waltham, MADirectorMilind Deshpande · Waltham, MAExec · DirectorSimon Read · Waltham, MADirectorMichael Esposito · Redondo Beach, CADirectorAndrew P. Walrath · Schenectady, NYDirectorRonald Rosenfarb · CAROLINA, Puerto RicoExec · DirectorTom B. Mccandless · Vancouver, British Columbia, CanadaDirectorJay A. Brammer · Carmel, INDirectorGrady J. Gaynor · Carmel, INExec · DirectorSimon Read · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗